Helicobacter pylori GroEL Seropositivity Is Associated with an Increased Risk of Opisthorchis viverrini-Associated Hepatobiliary Abnormalities and Cholangiocarcinoma
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Despite the synergistic effect of Opisthorchis viverrini and Helicobacter pylori co-infection on pathogenesis of severe hepatobiliary abnormalities (HBA) including advanced periductal fibrosis and replace with cholangiocarcinoma (CCA) have been established, the immune response to H. pylori in O. viverrini infected population has never been explored. Hence, this study aimed to investigate the antibody responses to 2 immunogenic H. pylori proteins in O. viverrini-infected patients with HBA and CCA. The risk analysis by multinomial logistic regression revealed that GroEL seropositivity was associated with higher risks of hepatobiliary abnormalities and CCA with adjusted odds ratios (95% confidence intervals) of 2.11 (95% CI=1.20-3.71, P=0.008) and 2.13 (95% CI=1.21-3.75, P=0.009), respectively. These findings indicate that GroEL seropositivity might be a biomarker for early detection of O. viverrini associated HBA and CCA.
Abstract
Despite the synergistic effect of Opisthorchis viverrini and Helicobacter pylori co-infection on pathogenesis of severe hepatobiliary abnormalities (HBA) including advanced periductal fibrosis and replace with cholangiocarcinoma (CCA) have been established, the immune response to H. pylori in O. viverrini infected population has never been explored. Hence, this study aimed to investigate the antibody responses to 2 immunogenic H. pylori proteins in O. viverrini-infected patients with HBA and CCA. The risk analysis by multinomial logistic regression revealed that GroEL seropositivity was associated with higher risks of hepatobiliary abnormalities and CCA with adjusted odds ratios (95% confidence intervals) of 2.11 (95% CI=1.20-3.71, P=0.008) and 2.13 (95% CI=1.21-3.75, P=0.009), respectively. These findings indicate that GroEL seropositivity might be a biomarker for early detection of O. viverrini associated HBA and CCA.
참고문헌 (28)
- Elkins DB, "A high frequency of hepatobiliary disease and suspected cholangiocarcinoma associated with heavy Opisthorchis viverrini infection in a small community in north-east Thailand", Trans R Soc Trop Med Hyg, 84, pp.715~719 (1990)[DOI]
- Sripa B, "Liver fluke induces cholangiocarcinoma", PLoS Med, 4, pp.e201~ (2007)[DOI]
- Banales JM, "Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENSCCA)", Nat Rev Gastroenterol Hepatol, 13, pp.261~280 (2016)[DOI]
- Kamsa-Ard S, "Cholangiocarcinoma trends, incidence, and relative survival in Khon Kaen, Thailand from 1989 through 2013: a populationbased cancer registry study", J Epidemiol, 29, pp.197~204 (2018)[DOI]
- Rizvi S, "Cholangiocarcinoma - evolving concepts and therapeutic strategies", Nat Rev Clin Oncol, 15, pp.95~111 (2018)[DOI]
- Nilsson HO, "elicobacter species identified in liver from patients with cholangiocarcinoma and hepatocellular carcinoma", Gastroenterology, 120, pp.323~324 (2001)[DOI]
- Deenonpoe R, "The carcinogenic liver fluke Opisthorchis viverrini is a reservoir for species of Helicobacter", Asian Pac J Cancer Prev, 16, pp.1751~1758 (2015)[DOI]
- Deenonpoe R, "Elevated prevalence of Helicobacter species and virulence factors in opisthorchiasis and associated hepatobiliary disease", Sci Rep, 7, pp.42744~ (2017)[DOI]
- Dangtakot R, "Co-infection of Helicobacter pylori and Opisthorchis viverrini enhances the severity of hepatobiliary abnormalities in hamsters", Infect Immun, 85, pp.e00009~e00017 (2017)[DOI]
- Sripa B, "Update on pathogenesis of opisthorchiasis and cholangiocarcinoma", Adv Parasitol, 102, pp.97~113 (2018)[DOI]
- Gao L, "Helicobacter pylori infection and gastric cancer risk: evaluation of 15H. pylori proteins determined by novel multiplex serology", Cancer Res, 69, pp.6164~6170 (2009)[DOI]
- ong H, "A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: Associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology", Int J Cancer, 13, pp.2942~2950 (2014)[DOI]
- Cai H, "Helicobacter pylori blood biomarker for gastric cancer risk in East Asia", Int J Epidemiol, 45, pp.774~781 (2016)[DOI]
- Blase JL, "Prediagnostic Helicobacter pylori antibodies and colorectal cancer risk in an elderly, caucasian population", Helicobacter, 21, pp.488~492 (2016)[DOI]
- Fernández de Larrea-Baz N, "Helicobacter pylori antibody reactivities and colorectal cancer risk in a case-control study in Spain", Front Microbiol, 8, pp.888~ (2017)[DOI]
- Murphy G, "Association of seropositivity to Helicobacter species and biliary tract cancer in the ATBC study", Hepatology, 60, pp.1963~1971 (2014)[DOI]
- Sripa B, "Advanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of interleukin-6", Hepatology, 50, pp.1273~1281 (2009)[DOI]
- "RStudio: Integrated Development for R"[URL]
- "Package “stats.” R: A language and environ-ment for statistical computing R Foundation for Statistical Computing" (2001)[URL]
- "Package “raster.”"[URL]
- "Package ‘ggplot2.’ R: A language and environment for statistical computing R Foundation for Statistical Computing"[URL]
- "Package “nnet.” R: A language and environment for statistical computing R Foundation for Statistical Computing"[URL]
- Jungblut PR, "Comparative proteome analysis of Helicobacter pylori", Mol Microbiol, 36, pp.710~725 (2000)[DOI]
- Kamiya S, "A virulence factor of Helicobacter pylori: role of heat shock protein in mucosal inflammation after H. pylori infection", J Clin Gastroenterol, 27(suppl), pp.35~39 (1998)[DOI]
- Takenaka R, "Helicobacter pylori heat-shock protein 60 induces inflammatory responses through the Toll-like receptor-triggered pathway in cultured human gastric epithelial cells", Microbiology, 150, pp.3913~3922 (2004)[DOI]
- Ferreira RM, "Helicobacter pylori cagA promoter region sequences influence CagA expression and interleukin 8 secretion", J Infect Dis, 213, pp.669~673 (2016)[DOI]
- Ahire D, "Variations in the multimerization region of the Helicobacter pylori cytotoxin CagA affect virulence", Oncol Lett, 13, pp.1444~1450 (2017)[DOI]
- ang S, "Dynamic expansion and contraction of cagA copy number in Helicobacter pylori impact development of gastric disease", mBio, 8, pp.e01779~e01816 (2017)[DOI]
